Hormones and the Laboratory — Understanding Endocrine Disorders Through Clinical Chemistry
The Language of Hormones: How the Laboratory Decodes the Endocrine System
The endocrine system is the body's chemical messaging network — a collection of glands that produce and secrete hormones directly into the bloodstream to regulate metabolism, growth, reproduction, fluid balance, and stress responses. It is the body's slow communication system, operating not in milliseconds like the nervous system, but in minutes, hours, and days — orchestrating long-term adaptations that shape who we are and how we function.
When this system malfunctions, the consequences ripple through virtually every physiological function. A thyroid gone quiet leaves a patient fatigued, cold, and mentally fogged. An adrenal gland in overdrive carves central obesity into the body and drives blood pressure to dangerous heights. A prolactin-secreting tumour robs a woman of her menstrual cycle and a man of his libido, often for years before anyone thinks to test.
Endocrine disorders — from thyroid disease to Cushing's syndrome to adrenal insufficiency — are diagnosed and monitored primarily through laboratory tests. There is no substitute. You cannot reliably diagnose hyperthyroidism by handshake, nor Cushing's syndrome by looking at a patient's face — though both may be suspected. The diagnosis lives in the numbers.
The medical laboratory scientist who understands the hypothalamic-pituitary axis, hormone feedback loops, and the analytical challenges of hormone measurement is an invaluable member of the endocrine diagnostic team. This is the science of listening to whispers — hormones measured at concentrations that would be lost in a single drop of water — and translating them into actionable clinical information.
1. Principles of Hormone Measurement: Listening to Whispers
Most hormones are present in the blood at picomolar to nanomolar concentrations — the equivalent of a pinch of sugar dissolved in an Olympic-sized swimming pool. Measuring them requires exquisitely sensitive assays and rigorous attention to pre-analytical variables.
The Two Main Analytical Platforms:
Immunoassay is the workhorse of routine endocrine testing. It uses antibody-antigen reactions to quantify hormones. Platforms include:
ELISA (enzyme-linked immunosorbent assay)
CLIA (chemiluminescent immunoassay)
ECLIA (electrochemiluminescence immunoassay)
Immunoassays are fast, automated, and widely available. But they have limitations:
Cross-reactivity — antibodies may bind to structurally similar molecules (e.g., progesterone assays cross-reacting with other progestogens)
Hook effect — at extremely high concentrations, antigen excess can saturate both capture and detection antibodies, producing a falsely low result
Matrix effects — interfering substances in the sample (lipids, proteins, heterophilic antibodies) can distort results
Mass spectrometry (LC-MS/MS) is the gold standard for many steroid hormones. It separates molecules by mass-to-charge ratio, allowing precise identification and quantification of closely related compounds. LC-MS/MS can distinguish:
Cortisol from cortisone
Testosterone from other androgens (androstenedione, DHEA)
Vitamin D metabolites
Mass spectrometry is more specific than immunoassay, but it requires expensive equipment, highly skilled operators, and is typically performed in reference laboratories. It is the tool of choice when immunoassay results are discordant with clinical presentation.
The Hypothalamic-Pituitary Axis: A Hierarchy of Control
Most endocrine systems operate through a hierarchical control loop:
The hypothalamus secretes releasing/inhibiting hormones into the portal circulation
These regulate the pituitary gland's secretion of tropic hormones (hormones that stimulate other glands)
Tropic hormones stimulate peripheral glands (thyroid, adrenal, gonads) to produce their effector hormones
Effector hormones feed back to suppress the hypothalamus and pituitary — completing the loop
This negative feedback is the basis of many diagnostic tests. If the peripheral gland fails (primary endocrine failure), the tropic hormone rises. If the pituitary fails (secondary failure), the tropic hormone falls. Understanding this hierarchy is essential to interpreting endocrine results.
2. Thyroid Disorders: The Master Regulator of Metabolism
(We've covered thyroid testing in depth in a previous post, but it merits revisiting in the context of the broader endocrine system.)
The hypothalamic-pituitary-thyroid (HPT) axis is a model of elegant feedback control:
TRH (thyrotropin-releasing hormone) from the hypothalamus → stimulates the pituitary
TSH (thyroid-stimulating hormone) from the pituitary → stimulates the thyroid
T4 (thyroxine) and T3 (triiodothyronine) from the thyroid → feedback to suppress TRH and TSH
TSH is the most sensitive marker of thyroid function. Because the feedback loop amplifies small changes in T4/T3 by several orders of magnitude, TSH rises exponentially when thyroid hormone falls, and falls to undetectable levels when thyroid hormone rises. A normal TSH effectively rules out significant thyroid dysfunction in ambulatory patients.
The Patterns:
| Condition | TSH | Free T4 | Free T3 |
|---|---|---|---|
| Primary hypothyroidism | High | Low | Low or normal |
| Subclinical hypothyroidism | High | Normal | Normal |
| Primary hyperthyroidism | Low | High | High |
| Subclinical hyperthyroidism | Low | Normal | Normal |
| Central hypothyroidism | Low or inappropriately normal | Low | Low |
| Euthyroid sick syndrome | Variable (often low) | Low | Low (non-thyroidal illness) |
Thyroid Antibodies: The Autoimmune Signatures
Anti-TPO (thyroid peroxidase antibodies): The marker of autoimmune thyroid disease. Present in Hashimoto's thyroiditis (the most common cause of hypothyroidism in adults) and in Graves' disease (where they are not pathogenic but indicate autoimmune background).
Anti-TSH receptor antibodies (TRAb): The pathological driver of Graves' disease. These antibodies bind to and activate the TSH receptor, causing unregulated thyroid hormone production. TRAb is also used in the third trimester of pregnancy to predict risk of neonatal thyrotoxicosis (antibodies cross the placenta).
Anti-thyroglobulin (TgAb): Used alongside thyroglobulin as a tumour marker in differentiated thyroid carcinoma (papillary, follicular). After thyroidectomy, thyroglobulin should be undetectable; rising TgAb or thyroglobulin suggests recurrence.
3. Adrenal Disorders: The Stress Response System
3.1 The Hypothalamic-Pituitary-Adrenal (HPA) Axis
The HPA axis is the body's central stress response system:
CRH (corticotropin-releasing hormone) from the hypothalamus → stimulates the pituitary
ACTH (adrenocorticotropic hormone) from the pituitary → stimulates the adrenal cortex
Cortisol from the adrenal cortex → feedback to suppress CRH and ACTH
Cortisol follows a circadian rhythm. It peaks in the early morning (6–8 AM) — the signal to wake — and reaches its nadir at midnight. This rhythm is essential to understanding cortisol interpretation. A morning cortisol of 300 nmol/L might be normal at 8 AM but severely deficient at 4 PM.
3.2 Cushing's Syndrome: When Cortisol Runs Rampant
Cushing's syndrome is caused by prolonged exposure to excess glucocorticoids. The causes are:
Exogenous (iatrogenic): Steroid therapy for asthma, arthritis, autoimmune disease — the most common cause globally
Endogenous: Adrenal adenoma/carcinoma (ACTH-independent), pituitary ACTH-secreting adenoma (Cushing's disease), or ectopic ACTH production (lung cancer, carcinoid tumours)
Clinical features are unmistakable in full-blown cases: central obesity, moon face, buffalo hump, purple striae (wide, bruise-like stretch marks), proximal myopathy (difficulty rising from a chair), hypertension, diabetes, and osteoporosis.
Laboratory Diagnosis of Cushing's Syndrome:
No single test is perfect. Guidelines recommend at least two of the following:
| Test | Method | Interpretation |
|---|---|---|
| Late-night salivary cortisol | Patient collects saliva at midnight | Loss of diurnal rhythm is an early marker. Midnight cortisol >5.8 nmol/L is suggestive. Convenient, non-invasive. |
| 24-hour urinary free cortisol (UFC) | Complete 24-hour urine collection | Elevated (>3 times ULN is highly specific). Requires meticulous collection — instruct patients carefully. |
| 1 mg overnight dexamethasone suppression test (DST) | Dexamethasone 1 mg at midnight; 9 AM cortisol | Normal suppression: cortisol <50 nmol/L. Non-suppression suggests Cushing's. Simple but less specific in stressed patients. |
Once Cushing's is confirmed, ACTH level distinguishes the source:
ACTH suppressed (<10 pg/mL): ACTH-independent (adrenal tumour)
ACTH normal/elevated (>10 pg/mL): ACTH-dependent (pituitary or ectopic)
Pituitary MRI and inferior petrosal sinus sampling (IPSS) further localize the source.
3.3 Adrenal Insufficiency: When Cortisol Fails
Primary adrenal insufficiency (Addison's disease) is caused by destruction of the adrenal cortex. In high-income countries, the leading cause is autoimmune (adrenalitis). In Africa, tuberculosis remains a major cause — the adrenal glands are seeded by TB, leading to caseous necrosis and destruction.
The deficiency affects both glucocorticoids (cortisol) and mineralocorticoids (aldosterone) .
Clinical features:
Fatigue, weight loss, anorexia
Hyperpigmentation — a hallmark of primary AI. Elevated ACTH stimulates melanocytes; the patient darkens like a tan that never fades, especially in palmar creases, scars, and mucous membranes
Postural hypotension, salt craving
Hyponatraemia, hyperkalaemia (the classic electrolyte pattern)
Laboratory Investigation:
| Test | Finding in Primary AI | Finding in Secondary AI (pituitary cause) |
|---|---|---|
| Short Synacthen test (SST) | Failure to rise: cortisol <500 nmol/L at 30 min | Failure to rise (same) |
| Basal ACTH | Markedly elevated (often >2× ULN) | Low or inappropriately normal |
| U&E | Hyponatraemia, hyperkalaemia, raised urea | Hyponatraemia only (no hyperkalaemia — aldosterone intact) |
| Renin/aldosterone | High renin, low aldosterone | Normal renin/aldosterone |
The Short Synacthen Test (SST) protocol:
Draw baseline cortisol
Administer 250 mcg tetracosactide (synthetic ACTH) IV or IM
Draw cortisol at 30 and 60 minutes
Normal response: Peak cortisol >500 nmol/L (or increment >170 nmol/L above baseline)
Failure to rise: Confirms adrenal insufficiency
Adrenal antibodies (21-hydroxylase antibodies) are positive in ~80% of autoimmune Addison's disease.
Critical clinical point: Adrenal crisis (hypotension, hypoglycaemia, hyponatraemia, hyperkalaemia) is a medical emergency. Treatment with IV hydrocortisone must not be delayed for confirmatory testing. Draw blood for cortisol and ACTH, then treat.
4. Disorders of the Hypothalamic-Pituitary-Gonadal (HPG) Axis
4.1 Male Hypogonadism: Testosterone Deficiency
Testosterone deficiency affects libido, erectile function, energy, muscle mass, bone density, and mood. Its prevalence increases with age, but it is not an inevitable consequence of ageing.
Investigation:
9 AM total testosterone (at least two occasions — testosterone is pulsatile and shows diurnal variation)
LH and FSH — distinguish primary from secondary hypogonadism
SHBG (sex hormone-binding globulin) — needed to calculate free testosterone (the biologically active fraction)
Prolactin — hyperprolactinaemia causes hypogonadism
Interpreting the pattern:
| Pattern | LH/FSH | Testosterone | Cause |
|---|---|---|---|
| Primary hypogonadism | High | Low | Testicular failure (Klinefelter syndrome, trauma, mumps orchitis, chemotherapy) |
| Secondary hypogonadism | Low or inappropriately normal | Low | Pituitary/hypothalamic failure (pituitary tumour, infiltrative disease, obesity, opioids) |
Free testosterone is calculated using total testosterone, SHBG, and albumin. It is particularly important in older men, in obesity (where SHBG is low), and in conditions altering SHBG (liver disease, hyperthyroidism).
4.2 Polycystic Ovary Syndrome (PCOS): The Most Common Endocrine Disorder in Women
PCOS affects 8–13% of women of reproductive age — making it the most common endocrine disorder in this population. It is a syndrome of hyperandrogenism and ovulatory dysfunction.
Rotterdam diagnostic criteria (2003) require 2 of 3 :
Oligo- or anovulation (irregular cycles, cycles >35 days)
Clinical or biochemical hyperandrogenism (hirsutism, acne, elevated testosterone)
Polycystic ovaries on ultrasound (≥20 follicles per ovary, or ovarian volume ≥10 mL)
Laboratory findings in PCOS:
Elevated LH:FSH ratio (>2:1) — but this is not diagnostic and may be absent
Elevated total or free testosterone
Elevated DHEAS (adrenal androgen) in some cases
Low SHBG — free testosterone often more elevated than total testosterone
Insulin resistance — elevated fasting insulin, glucose intolerance; metabolic syndrome is common
Differential diagnosis: Other causes of hyperandrogenism must be excluded — non-classic congenital adrenal hyperplasia (21-hydroxylase deficiency) , androgen-secreting tumours , Cushing's syndrome , and hyperprolactinaemia.
4.3 Menopause and Premature Ovarian Insufficiency (POI)
The menopausal transition is characterised by rising FSH as the ovaries' capacity to produce oestradiol declines.
Diagnosis of menopause: FSH >30 IU/L on two occasions (>4 weeks apart) in a woman over 45 with appropriate symptoms (amenorrhoea, hot flushes, night sweats).
Premature ovarian insufficiency (POI): Menopause occurring before age 40. This requires investigation:
Karyotype (Turner syndrome, other X chromosome abnormalities)
FMR1 premutation (fragile X premutation — associated with POI)
Ovarian antibodies (autoimmune POI)
Adrenal antibodies (autoimmune polyendocrine syndrome)
5. Prolactin and Hyperprolactinaemia: The Dopamine-Dependent Hormone
Prolactin is secreted by the anterior pituitary and is tonically inhibited by dopamine from the hypothalamus. Anything that disrupts dopamine delivery or action causes prolactin to rise.
Hyperprolactinaemia causes:
Galactorrhoea (inappropriate lactation — not always present)
Menstrual irregularity or amenorrhoea
Hypogonadism (low libido, erectile dysfunction in men, infertility in both sexes)
Causes of Elevated Prolactin:
| Category | Examples |
|---|---|
| Physiological | Pregnancy, breastfeeding, stress, exercise, sleep, nipple stimulation |
| Pharmacological | Dopamine antagonists: metoclopramide, haloperidol, risperidone, domperidone (very common cause globally); also antidepressants, opiates |
| Pathological | Prolactinoma (pituitary adenoma — most common pituitary tumour), hypothyroidism (TRH stimulates prolactin), renal failure, liver disease, chest wall trauma |
The Macroprolactin Trap
Macroprolactinaemia is a common laboratory pitfall. Macroprolactin is prolactin bound to IgG antibody — a "big-big" complex that is detected by immunoassays but is biologically inactive. The patient has no symptoms of hyperprolactinaemia despite a high prolactin reading.
Before investigating a raised prolactin clinically, laboratories should perform PEG precipitation — polyethylene glycol precipitates macroprolactin, allowing measurement of monomeric (true) prolactin. If the true prolactin is normal, no further investigation is needed.
Investigating True Hyperprolactinaemia:
Pituitary MRI — to identify prolactinoma (microadenoma <10 mm, macroadenoma >10 mm)
Thyroid function tests — rule out hypothyroidism
Renal function — rule out renal failure
Review medications — common cause
6. Growth Hormone (GH) and IGF-1: The Growth Axis
GH is released episodically from the pituitary in pulses, primarily during sleep. A single random GH measurement is almost useless — it may be undetectable in a healthy person or elevated in a patient with acromegaly, depending on when the sample was drawn.
IGF-1 (insulin-like growth factor 1) , produced by the liver in response to GH, provides a stable, integrated measure of GH activity. It has no significant diurnal variation and is the first-line screening test for GH disorders.
Acromegaly (excess GH in adults):
IGF-1 elevated for age and sex
Confirmation: oral glucose tolerance test (OGTT) — 75g glucose load; GH should suppress to <1 mcg/L. Failure to suppress confirms acromegaly
GH deficiency:
IGF-1 low for age (first-line screening)
Confirmation requires stimulation tests (insulin tolerance test, glucagon test) — GH fails to rise above threshold
Conclusion: Decoding the Chemical Conversation
The endocrine system communicates in nanomolar whispers — concentrations so low they would be undetectable without the exquisite sensitivity of modern immunoassays and mass spectrometers. The laboratory's job is to amplify these whispers, to translate them into numbers, and to present them in a framework that makes sense of the body's chemical conversation.
From the morning cortisol that catches adrenal insufficiency to the late-night salivary cortisol that unmasks Cushing's. From the elevated TSH that reveals subclinical hypothyroidism to the FSH that signals the end of reproductive years. From the macroprolactin that would have led to unnecessary pituitary imaging to the IGF-1 that screens for acromegaly with a single blood draw — hormones tell us stories about homeostasis, disruption, and recovery.
Understanding how to measure and interpret these stories — and the analytical challenges inherent in hormone testing — is one of the most sophisticated skills in the clinical laboratory scientist's repertoire. And for the patient on the other end of the result, understanding what those numbers mean is the first step toward reclaiming their health.
Your Hormones. Your Numbers. Your Understanding.
Whether you're navigating a thyroid diagnosis, investigating fatigue, or trying to understand what your hormone results mean, knowledge is power.
Visit our free interpretation tool at:
https://VincentAkwas.github.io/lablens
Get instant, detailed explanations for your thyroid function tests, cortisol, testosterone, prolactin, and all your endocrine laboratory results — with clinical commentary that helps you understand what your numbers mean and what questions to ask next.
Because hormones speak a language. And you deserve to understand it.
Nice 👍
ReplyDelete